FIELD: medicine.
SUBSTANCE: therapy of exudative otitis media is ensured by introduction of antibacterial, mucolytic, vasoconstrictive and proteolytic agents. It is combined with transtympanic introduction of 1.5% sodium deoxyribonucleate solution (Derinate) dosed 0.5 ml every second day into tympanic cavity. The therapeutic course is 4 injections of Derinate.
EFFECT: higher clinical effectiveness, reduced time of auditory perception threshold restoration.
3 tbl, 2 ex, 1 dwg
Title | Year | Author | Number |
---|---|---|---|
AGENT AND METHOD OF TREATING EXUDATIVE OTITIS MEDIA IN CHILDREN | 2014 |
|
RU2550966C1 |
METHOD OF TREATING EXUDATIVE OTITIS MEDIA IN CHILDREN | 2010 |
|
RU2424821C1 |
DIAGNOSTICS METHOD OF ACOUSTICAL PIPE DISEASES | 2007 |
|
RU2342072C1 |
METHOD OF OTOSALPINX INFLATION | 2008 |
|
RU2401666C2 |
METHOD FOR TREATING INFLAMMATORY DISEASES OF AURIS MEDIA | 2005 |
|
RU2288749C2 |
METHOD OF TREATING EXUDATIVE OTITIS MEDIA | 2015 |
|
RU2587849C1 |
METHOD OF MYRINGOPLASTY | 2011 |
|
RU2485917C2 |
METHOD OF TREATING SECRETORY OTITIS MEDIA IN CHILDREN | 2013 |
|
RU2539426C1 |
METHOD FOR ENDOSCOPICALLY ASSISTED TYMPANOPLASTY | 2006 |
|
RU2306914C1 |
METHOD OF DIAGNOSING EXUDATIVE OTITIS MEDIA | 2012 |
|
RU2487667C1 |
Authors
Dates
2009-06-20—Published
2008-03-04—Filed